What partnership looks like in practice.
/
Portfolio
(01)
Companies Impacting Healthcare
Biocerta
Biocerta is developing CertaPath, a drug sensitivity testing platform that uses a patient's own tumor tissue to identify which FDA-approved therapies are most likely to work. The technology gives oncologists real data on drug activity against individual tumors, replacing generalized treatment protocols with personalized treatment decisions. Biocerta holds an exclusive license from the University of Miami.
/
Problems to solve
(02)
How We Have Helped

Ophthalmology
Commercializing a diabetic retinopathy detection, staging, and treatment platform to improve access and compliance among patients with Type II diabetes.
Ophthalmology

Pharmacy Access
Making prescription drugs more readily accessible to patients through primary care physician practices.
Pharmacy Access

Payor Relations
Resolving medical provider-payor issues through network contracting and fee schedule negotiation services.
Payor Relations

Revenue Cycle Management:
Reducing costs in medical billing, coding, and collections through advanced revenue cycle management solutions.
Revenue Cycle Management

Pharmaceutical Services
Designing novel pricing and delivery models to lower the cost of high-utilization prescription drugs.
Pharmaceutical Services:

Infusion Services
Making infusion therapy more accessible through deployment of practice- based administration of specialty medications.
Infusion Services
